Paula Loredo Siminovich

Ms. Paula Loredo Siminovich

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2024
Verified
Book Chapter
Closed access
MBMaria Renita Burg
Maria Renita Burg
MCMiria Elisabete Bairros de Camargo
Miria Elisabete Bairros de Camargo
DRDarla Silvana Risson Ranna
Darla Silvana Risson Ranna
PSPaula Loredo Siminovich
Paula Loredo Siminovich
CGCarlos Eduardo Gasparetto
Carlos Eduardo Gasparetto
PCPaulo Roberto Cardoso Consoni
Paulo Roberto Cardoso Consoni
A atenção à saúde da população idosa tem como porta de entrada preferencialmente a Atenção Primária à Saúde (APS). A APS constitui o primeiro contato de indivíduos, famílias e comunidades com o Sistema Único de Saúde, trazendo os serviços de saúde o mais próximo possível aos lugares de vida e trabalho das pessoas, e significa, na Rede de Atenção à Saúde, o primeiro elemento de um processo contínuo de atenção (SBIBAE, 2019).

1 June 2023 in ABC Heart Failure & Cardiomyopathy
Verified
Journal Article
Closed access
PDF file
LDLuiz Claudio Danzmann
Luiz Claudio Danzmann
LFLiciani de Mello Feliciano
Liciani de Mello Feliciano
EKElisa Kalil
Elisa Kalil
PSPaula Loredo Siminovich
Paula Loredo Siminovich
MNMarianna de Moura Nora
Marianna de Moura Nora
A rare – or not so rare – condition? Restrictive cardiomyopathies, caused by primary pathologies of the heart muscle, are considered rare diseases, corresponding to about 5% of all cardiomyopathies. The most frequent form of restrictive cardiomyopathy is cardiac amyloidosis (CA), which can be considered a benchmark since, with the availability of diagnostic technologies, its detection has been made much more frequent, associated with the fact that there are effective treatment possibilities. […] Restrictive Cardiomyopathies: What’s New on the War [...] A rare – or not so rare – condition? Restrictive cardiomyopathies, caused by primary pathologies of the heart muscle, are considered rare diseases, corresponding to about 5% of all cardiomyopathies. The most frequent form of restrictive cardiomyopathy is cardiac amyloidosis (CA), which can be considered a benchmark since, with the availability of diagnostic technologies, its detection has been made much more frequent, associated with the fact that there are effective treatment possibilities. […] Restrictive Cardiomyopathies: What’s New on the War

30 July 2023
Verified
Book Chapter
Closed access
CGCarlos Eduardo Gasparetto
Carlos Eduardo Gasparetto
CRCatarina Roos Mariano DA Rocha
Catarina Roos Mariano DA Rocha
GSGiovana Nunes Santos
Giovana Nunes Santos
IFIsabela Zoppas Fridman
Isabela Zoppas Fridman
ISIsadora Sandi
Isadora Sandi
PSPedro Augusto Horbach Salzano
Pedro Augusto Horbach Salzano

14 March 2025 in Cardiogenetics
Verified
Journal Article
Open access
PDF file
AGAndrea Greco
Andrea Greco
EBEstefanía Martínez Barrios
Estefanía Martínez Barrios
JCJosé Cruzalegui
José Cruzalegui
SCSergi Cesar
Sergi Cesar
FCFredy Chipa
Fredy Chipa
Oscar CampuzanoOscar Campuzano
Oscar Campuzano
The GPD1L gene encodes a small cytoplasmic protein that is involved in the regulation of sodium currents. Alterations in this gene have been associated with Brugada syndrome. This rare arrhythmogenic syndrome is characterized by a typical electrocardiographic pattern, incomplete penetrance, variable expressivity, and risk of sudden cardiac death. To date, few families with a clinical diagnosis of Brugada syndrome caused by a rare alteration in the GPD1L gene have been reported worldwide. The increase in data focused on genetic variants allows us to improve the interpretation of their role in Brugada syndrome. In our study, we have compiled the GPD1L variants reported so far in patients with a definitive clinical diagnosis or suspected Brugada syndrome. We performed an exhaustive update and interpretation of each variant following the guidelines of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Our results showed that none of the variants described to date can be classified as truly harmful in Brugada syndrome. Despite this fact, more clinical and genetic data are needed to definitively rule out the GPD1L gene as a cause of Brugada syndrome. In summary, to date, there is insufficient evidence to conclude a definitive association between GPD1L and Brugada syndrome.

21 July 2023
Verified
Book Chapter
Open access
PDF file
MCMiria Elisabete Bairros de Camargo
Miria Elisabete Bairros de Camargo
CGCarlos Eduardo Gasparetto
Carlos Eduardo Gasparetto
LDLana Caroline Palaver Dall’ago
Lana Caroline Palaver Dall’ago
LCLiara Eickhoff Coppetti
Liara Eickhoff Coppetti
PSPaula Loredo Siminovich
Paula Loredo Siminovich
MBMaria Renita Burg
Maria Renita Burg
Introduction: The COVID-19 pandemic started in March 2020 and is marked by a high number of infected. The symptoms of the disease are variable and the most severe cases occurred mainly in elderly patients and those with previous comorbidities. Objectives: To profile infected patients in the city of Canoas/RS, who required hospitalization for COVID-19; whose hospital discharge happened in January 2021. Method: This is a descriptive, exploratory, retrospective and documentary study, with a quantitative approach, where 51 medical records of patients living in Canoas/RS were analyzed, and had the hospital discharge in January 2021 with a positive diagnosis for the COVID-19 virus, at the city´s benchmark hospital. Results: The profile that was found: male, with an average age of 55,6 years old, white and single. The average hospitalization was 6,8 days. About the medications, the most frequently used was dexamethasone and, among other care prescribed after hospital discharge, the most known was the follow-up at the Basic Health Unit. Approximately 34 patients had some comorbidity and, also, more than half had previously used continuous medications. Only three patients in the study responded affirmatively about exposure to COVID-19 and the main symptoms presented by patients in general were dyspnea, cough and fever. Final considerations: The study shows that patients with advanced age and with chronic diseases are at greater risk of developing the severe form of COVID-19. The high rate of transmissibility can be observed by the absence of information regarding the natural history of the disease. DOI:https://doi.org/10.56238/Connexpemultidisdevolpfut-035

12 November 2024
Verified
Book Chapter
Closed access
PCPaulo Roberto Cardoso Consoni
Paulo Roberto Cardoso Consoni
PSPaula Loredo Siminovich
Paula Loredo Siminovich
CGCarlos Eduardo Gasparetto
Carlos Eduardo Gasparetto
MCMiria Elisabete Bairros de Camargo
Miria Elisabete Bairros de Camargo
MBMaria Renita Burg
Maria Renita Burg
A visão é responsável, naturalmente, por 85% das informações processadas no cérebro, e as deficiências visuais não estão distribuídas equilibradamente entre os grupos etários. Mais de 82% de todas as pessoas cegas no mundo são maiores de 50 anos, apesar de esse grupo representar apenas 19% da população mundial (Brasil, 2022).